Some hepatitis C patients developed resistance to Vertex Pharmaceuticals' telaprevir after two days of treatment and had to take multidrug cocktails to sustain the medicine's effectiveness, a study showed. Researchers found that telaprevir kills off normal viral particles along with rapidly mutating ones, but resistant mutants are left to multiply.

Full Story:

Related Summaries